Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT06341712
Title Effects of Maintenance Cabozantinib+BSC Versus BSC in Children and AYA With Osteosarcoma (CabOSTar)
Acronym CabOSTar
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors Ipsen
Indications
Therapies
Age Groups: adult | child
Covered Countries USA | SWE | POL | NLD | ITA | IRL | GBR | FRA | ESP | DNK | DEU | CAN | BEL | AUT


No variant requirements are available.